Figures & data
Table 1. Composition of various formulations of Diclofenac sodium (DFS) used for ocular disposition studies.
Figure 2. SEM of PEO N10, DFSfree and DFSfree + DFS:IR1:1(3 + 1) films at 25×, 70× and 300× magnification.
![Figure 2. SEM of PEO N10, DFSfree and DFSfree + DFS:IR1:1(3 + 1) films at 25×, 70× and 300× magnification.](/cms/asset/63f6bc63-e066-496e-afdb-8d9c98ec0f01/idrd_a_1256000_f0002_b.jpg)
Figure 3. Percentage release of DFS up to 24 h form various ion exchange resin formulations and marketed ophthalmic solution.
![Figure 3. Percentage release of DFS up to 24 h form various ion exchange resin formulations and marketed ophthalmic solution.](/cms/asset/74c77eaf-be69-413b-a80e-7a0fd2a9fb60/idrd_a_1256000_f0003_b.jpg)